PEMBERIAN DESFERAL SEBAGAI INTERVENSI KEPERAWATAN DALAM MENGATASI DAMPAK HEMOSIDEROSIS AKIBAT TRANSFUSI BERULANG PADA AN.A DENGANTHALASEMIA(Studi Kasus di RSUD.Dr Saiful Anwar Malang)
| Main Author: | UTAMI, NONNY PUTRI |
|---|---|
| Format: | Thesis NonPeerReviewed |
| Terbitan: |
, 2011
|
| Subjects: | |
| Online Access: |
http://eprints.umm.ac.id/19518/ |
Daftar Isi:
- Thalassemia patients dependent on transfusions to maintain hemoglobin levels (Hb) is sufficient for tissue oxygenation. Providing continuous transfusions in patients with thalassemia done to maintain the levels haemohlobin. This can lead to transfusional hemosiderosis (HT) is a state where there is accumulation of iron levels in organs or in the blood of the patient. To reduce the likelihood of HT then attempted delivery medication to help increase iron excretion via the urine (Iron Chelation Therapy) with drug Desferrioxamine (Desferal). This case study aims to describe the implementation of desferal therapy for hemosiderosis impact on An.A with thalassemia. Design case study used is descriptive, the subjects in these case studies is a son of patients suffering from thalassemia in room 7B Hospital Dr. Saiful Anwar Malang. Descriptive method of writing done with a case study approach through engineering: diagnose, physical assessment, observation, interview. Study the documentation and literature study that used data analysis is pattern matching approach, comparing theoretical data with real client data. Having obtained the data corresponding to the real condition of the client then determined the results of implementation. The results of the implementation of nursing administration desferal against An.A not be evaluated because it is based on physical examination of clients, has not seen significant changes, the skin color of the client was still dark grayish anemis and clients, supported by other things not yet done a re-examination of ferritin levels in An.A. With limited data and lack of supporting research into the reasons why the administration has yet to be evaluated desferal.